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Abstract 
 Acute and chronic morphine administration can significantly reduce ischemia-
reperfusion injury of the rat heart. However, the molecular mechanisms mediating the 
protective effect of morphine are not yet fully elucidated. Concurrently, there is a lack 
of information about the effects of the long-term action of morphine on heart tissue. 
 Therefore, in the first part of the project, we studied the effect of long-term 
administration of high doses of morphine (10 mg/kg/day, 10 days) on rat heart tissue. In the 
second part of the project, we investigated the effect of 1 mM morphine on viability and redox 
state of rat cardiomyoblast cell line H9c2 that was influenced by oxidative stress elicited by 
exposure to tert-butyl hydroperoxide (t-BHP). 
 Our experiments have shown that long-term morphine administration affected neither 
- -AR), but almost doubled 
the number of the dominant isoforms of myocardial adenylyl cyclase (AC) V/VI and led to 
supersensitization of AC. At the same time, proteomic analyses revealed that long-term 
morphine administration was associated with significant changes in the left ventricular 
proteome. In particular, there was an increase in the expression of heat shock proteins (HSP). 
Increased expression of HSP27 was concomitantly accompanied by increased 
phosphorylation of this protein. Whereas, after a 3-days drug abstinence phosphorylation 
of HSP27 further increased, after a 6-days abstinence its phosphorylation returned to the 
control level. Conversely, there were no alterations in the levels of proteins involved in the 
regulation of oxidative stress.  
 In the second part of our project, we have shown that 1 mM morphine can 
significantly protect the H9c2 cell line against oxidant injury induced by t-BHP. This 
protective effect of morphine was at least partially mediated by the simultaneous activation 
of the p38 MAPK and PI3K/GSK- signaling pathways. Morphine also increased the total 
antioxidant capacity of cells and reduced protein carbonylation, lipid peroxidation and 
production of reactive oxygen species. Preincubation with morphine reduced the negative 
impact of t-BHP on all the parameters of cellular redox state described above. 
 In summary, our experiments show that long-term administration of high doses 
of morphine to rats significantly affects myocardial AC signaling and leads to numerous 
changes in the cardiac tissue proteome. In vitro, morphine may have strong antioxidant effects 
and can considerably protect H9c2 cells against the oxidative stress. 
Keywords: morphine, heart, proteomics, adenylyl cyclase, heat shock proteins, H9c2 cells, 
oxidative stress, PI3K, GSK-  
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2.1. Morfin  
 
 Papaver somniferum L.).   
z 
  000 - 3 
   
3   
  makovic  opia    - 
v   (Schiff, 2002). 
.  analgezii, 
ale  ,   
 , 
rost  - 15 %), 
kodein (1 - 3 %), noskapin (4 - 8 %), papaverin (1 - 3 %) a tebain (1 - 2 %) 
a Stein, 2006). Morfin byl z 
Jako 
 morfin  ji ve 30. letech 19. , 
ale k     
s jehlou v 50. letech 19.    morfin   
 jako  estezie 
(Brownstein, 1993).  
 Z 
(Hamilton a Baskett, 2000). 
 analgezie navozuje morfin i euforii, sedaci . 
 . 
samotnou  
   tak  jako 
bolest   
  
a (Stoelting a Miller, 2007).  
  
2.1.1.  
 Morfin   (viz 
obr. 1). 
na pozici C6 
  
analgezi morfin by nemohl  
 (CNS)  
Morfin je   
O-acetylaci  heroin (Andersen et al., 2003; 
Trescot et al., 2008).   
 
Obr. 1: renu. 
 
2.1.2. Metabolismus a farmakokinetika  
 B7 
-  izoformy  s 
glukuronovou kyselinou za vzniku morfin-3-glukuronidu (M3G) a morfin-6-glukuronidu 
(M6G) (Stone et al., 2003). K metabo
 . Glukuronidy jsou p  t
a  (Christrup, 1997).  
  
( ), k p.o.
bol et al., 2003). Po i.v.  k velmi 
. P
Spolu s 
plas trace morfinu  i k  , 
metabolismu a exkreci (Brunk a Delle, 1974). Po i.m.  morfin rychle , 
jeho efekt nastupuje po 15   a  po 45  90 
. C    hodiny (Stoelting a Miller, 2007). 
dosahuje b odin po i.m. 
  aplikaci. p.o. 
z  ,  
, a v plas tak  metabolity M3G a M6G 
nad m morfinem (Brunk a Delle, 1974). 
  je morfin konvert  55 % na M3G a z 10 % na 
M6G
i.v.  p.o.  % morfinu
p.o. 
  ou   
1993). 
 molekuly  
hema v  (Yoshimura et al., 
1973). M  a vykazuj  analgezie. Pokud 
,  jeho 
a  dokonce  morfin (De Gregori et al., 2012). 
 et al., 1996). 
naopak velmi malou afinitu k OR 
 hyperalgezie 
(z  ), allodynie 
(Andersen et al., 2003).  
 Novorozenci u 
 
 
e (Rang et al., 2003).   
 
2.1.3.   
 P  , 
analgezie vykazuje . Vzniklo tak 
  deri
  
 (Brownstein, 1993).  
 m  
v  
i  Tolerance se projevuje m citlivosti organismu k  
  naprostou 
  rojevuje se 
ojena s   psychickou 
(Taylor a Fleming, 2001). 
 Mechanismus vzniku tolerance 
 komplex  r (desenzitizace 
a internalizace), s ch transduk  (regul  
nukleotidy (G-proteiny), adenylyl a (AC), a (GC) a 
proteiny G- ) a n  jejich obvody
 -methyl-D- (NMDAR)  
/oxid dusnat  (NO) (Pasternak, 2007), viz obr. 2.   
 
Obr. 2: 
vzniku tolerance (upraveno podle Pasternak, 2007).  Po nav  
-
 Aktivuje GC 
vou 
B) S-
podjednotky NMDAR (Pasternak, 2007). C) 
n na peroxyni    
- ) zapojen  do 
 a Mn superoxid  
(MnSOD)   




oblast), pokampus) a k
a  (Volkow et al., 2003).  se rychle 
 
. R   
   , tedy v 
.  drog ale 
dopaminu. Tento hypodopa deregulaci 
    
, jako je  . 
v    dysfunkci ho kortex  
u  vede k (Volkow et al., 2002).   
 Opioidy se z jejich 
  
opioid  rizik 
s 
  opioidu tomu,  
  (Ling, 2017).  
 Vedle   sedace, 
(Benyamin et al., 2008). 
jede   opioidy zaznamenalo  s chronickou 
a 92 %  s  
i  v  schopnost 
. Ve studii  bylo 
avost je 
k  (Gregorian et al., 2010). 
   
 (Rang et al., 2003; Trescot et al., 2008). 
 morfinu       
1) m histaminu 
M  
2) m  
  
3) m  
M  
et al., 2008). 
4) P  em  
 
do mozku a tak se  
5) Spasmem        
M
a  
6)    ve 
 
 nevolnost  
 , 
 
(Stoelting a Miller, 2007; Trescot et al., 2008). 
7)  parasympatiku                                                                                       
 bradykardii (z  
 (Rang et al., 2003; 
Stoelting a Miller, 2007).  
8)  
P   
modulaci
a   
(Stoelting a Miller, 2007).   






toleranci    . Tolerance 
pouze na , 
s tak  opioidu bez 




 P    opioidy   
v  .  70. letech 20. 
 
(Akil et al., 1998). 
endorfiny, dynorfiny a nociceptiny, kt  pro-enkefalinu, 
pro-opiomelanokortinu, pro-dynorfinu a pro-nociceptinu (Pugsley, 2002). 
 , kde 
hr  analgezie, 
v , v modulaci  
(Benarroch, 2012).  v   
 agonistou -AR noradrenalinem i enkefaliny (Wilson et al., 1980). 
D  tak k   
V -AR 
signalizace enkefaliny 2+ a s 
spojenou kontraktilitu srdce
(Pepe et al., 1997; Xiao et al., 1997). K produkci 
EOP ale ne pouze v . nkefaliny se vytv  
kardiomyocytech (Springhorn a Claycomb, 1992). Endorfiny se pak  
 im  
a    (Rittner 
et al., 2001). 
 K  endomorfin-1 
a endomorfin-2 (Zadina et al., 1997), doposud ale nebyl nalezen 
prekurzor (Trigo et al., 2010).  navozuje endomorfinu 
se (Wilson et al., 2000).  se 
endomorfin  
ale   
slab . V se proto 
v  (Wang et al., 
2017)  analgezie jako morfin, 
s (Zadina et al., 2016). 
 V  
identickou strukturu jako morfin  z Papaver somniferum.  
roce 1985 z (Goldstein et al., 1985), ale dlouhou dobu 
  
  morfinu z katabolitu dopaminu - tetrahydropapaverolinu 
(Grobe et al., 2010). 
 





 OR typy:   MOR)  (kappa: KOR)  (delta, DOR), 
 (Minami a Satoh, 
1995).  eden v 
OR, je uvedeno 
v tabulce 2.  
 
 ORL1 (opioid receptor-like 1) (Mollereau et al., 1994)
EOP  jako receptor pro nociceptin/orphanin  peptid - NOR 
(Toll et al., 2016).  
Tabulka 1: Selektivita EOP a morfinu k MOR, DOR a KOR. 
  MOR DOR KOR  
-Endorfin +++ +++ +++ 
Leu-enkefalin + +++ - 
Met-enkefalin ++ +++ - 
Dynorfin ++ + +++ 
Morfin +++ + + 
Ki (nM) 0,26  8,6* 358* 52* 
 -
k MOR, ale s *Hodnoty Ki 
k i  receptoru (Chen et al., 
1993). 
 
Tabulka 2: efekt a OR, DOR a KOR. 
  MOR DOR KOR  
Analgezie:       
 +++ - - 
 ++ ++ + 
 ++ - ++ 
 +++ ++ - 
 ++ - + 
* ++ ++ + 
Euforie +++ - - 
Dysforie - - +++ 
Sedace ++ - ++ 
 +++ - + 
(+) s -  
*  
 
 T  skupiny OR  
1 - 3 (Cadet, 2004) 1 - 3 (Wollemann et al., 1993) 
a 1 - 3 (Traynor a Elliott, 1993). Dietis et al. (2011) 
by tato klasifikace  
a   
funkce). V doposud  pod
z celou skupinou OR. Z toho
na skupin  
a) b)  c)  s 
proteiny, d) 
, e) kombinace a  d 
(Dietis et al.,  2011).  
pro  u potkan    variant jsou 




2.3.2.        
  CNS, kde 
  skupiny (Mansour et al., 
1995)  OR i v 
distribuce MOR, KOR a DOR u potkana a  je uveden v tabulce 3. 
 V  PCR, 
polymerase chain reaction (Wittert et al., 1996). 
 byl ale MOR  v 
kardiomyocytech (Head et al., 2005) potvrzeny, 
kdy  
a   v  komory potkana (Treskatsch 
et al., 2016).  
 Spekulace dlouho panovaly i kolem distribuce 
srdci. V ze  byly 
PCR  jistotou y pouze 
(Bell et al., 2000). 
qPCR an  z nekropsi   
pouze KOR a  
pohybovala exprese kolem 105-107 , byla v 
 exprese 3,8 x 103 3 (Peng et al., 
2012). V roce 2014  
 nekropsie. Tato studie  ala  MOR, DOR 
i KOR v m srdci. MOR a DOR byly  kardiomyocytech i v 
KOR byl lokal   kardiomyocytech 
(Sobanski et al., 2014). DOR byl  in vivo 
(Villemagne et al., 2002). 
 
v  oblastech  s  
a (Toll et al., 2016). 
Tabulka 3: Exprese OR v   
 Potkan  
 MOR DOR KOR MOR DOR KOR 
Srdce + + + + + + 
 + + + - + + 
 + + - - - + 
 - + +      
      + + + 
 + + + + + + 
 + + +      
Ledviny + + + - + + 
Nadledviny + + + + + + 
      - + + 
Slezina + + + - - + 
Varlata + + +      
 + + +      
 + + +      
Endotel - - -      
Synovium - - -      
      - + + 
         + + 
(+) -
(Wittert et al., 1996; Treskatsch et al., 2016) (Sobanski et al., 2014)
(Wittert et al., 1996) (Salemi et al., 2005; Peng et al., 2012). 
2.3.3.  
 OR -proteiny (GPCR, G protein-coupled 
receptor
v - 70 % 
(Jordan a Devi, 1998). NOR je s - 62 % (Meunier et al., 
2000)  charakteristickou 
-  
 
 ICS3), ext ncem a cytoplaz
Na 
(Waldhoer et al., 2004; 
Rosenbaum et al., 2009). 
ECS3 (Meunier et al., 
2000). Schemat obr. 3.  
 andy s 
  vlastnostmi. Vazba lig
-proteinu (Salazar et al., 2007; Rosenbaum et al., 2009; 
Venkatakrishnan et al., 2013)
-proteinem, 




k receptoru a  
(Rosenbaum et al., 2009).  
 
Obr. 3: Struktura  receptoru. Vlevo: ECS1  
I  VII:  - segmenty; ICS1   
 
TM III a ECS2*. Vpravo: 
sedmi -  OR  vrchu - ext
strany (upraveno podle Waldhoer et al., 2004). vysoce 
 iny GPCR.  
 
ligandem (Venkatakrishnan et al., 2013).  
  
2.3.4.  
 OR   o a Gi proteiny (Connor a Christie, 
1999). V -proteiny  
 dimeru
  podjednotky od 
receptoru a G  dimeru (Hamm a Gilchrist, 1996). Ak  a G  pak 
 . 
 
2.3.4.1.  (AC) 
 V 
AC I  IX) a jeden gen AC X)
izoformy s proteiny a je 
- (Sunahara a Taussig, 2002). 
 i/o podjednotka inhibuje pouze AC I, V a VI (Sunahara et al., 1996; 
Sunahara a Taussig, 2002). Akti podjednotkou G , 
(Bian et al., 2012).   
 V  i izoformy AC (IV-








i/o a G  vede 
k inhibici AC I, V, 
(Schallmach et al., 2006). 
 
h Hladina cAMP moduluje 
aktivitu h -  (Ih)
larizace,  
 
 , do 
y cAMP-  A (PKA), 
 k (Williams 
et al., 2001). -  
faktoru CREB (cAMP response element-binding protein -  cAMP 
 
(CRE, cAMP response element) v  a  
indukuje expresi ( ) 
 
a   (Mayr 
a  Montminy, 2001).  
 
2.3.4.2.  C  (PLC ) 
 PLC je  (Murthy a Makhlouf, 1996).   
-4,5-  (PIP2) na diacylglycerol (DAG) 
a inositol 1,4,5- 3).  IP3  
Ca2+  DA - PKC (Barry a Zuo, 2005).  
Rod se  struktury 
a   : 1)  
(izoenzymy ), jejich aktivace je  na Ca2+, fosfatidylserinu (PS) a DAG; 
2) izoenzymy  ), Ca2+, k  PS a DAG; 
3)  ), Ca2+ a DAG, k  (shrnuto 
v publikaci Way et al., 2000). PKC ma   spektrum  
(n  )
 (Bian et al., 2012). 
 aktivace OR s 
regulovat  AC. Rubovitch et al., ( PKC 
 plaz
Ca2+ Ca2+ 
orem AC. Chakrabarti et al., i 
-  k fosforylaci G- . Tato fosforylace 
 podjednotky G  stimulovat aktivitu AC II. 
(Mao, 1999)   OR na NMDAR 
(Chen a Huang, 1991)
interakci mezi Mg2+ a (Chen a Huang, 1992)
v 




 protein- (Jan a Jan, 1997). m 
k aktivaci K+ 2+ (North, 1986; 
Standifer a Pasternak, 1997; Williams et al., 2001). Excita
 (acetylcholin 
a    -  GABA a glycin)  
(North, 1986; Williams et al., 2001). 
  
v 2+  (Smith a Stevens, 1995; Wang et al., 
2000) K+ et al., 1995, 2004). 
 
2.3.4.4. Fostatidylinositol-3-  (PI3K) 
Podjednotka G   (Maier 
et al., 1999). 3K fosforyluje PIP2 v 
fosfatidylinositol-3,4,5-  -homology 
za  -  PKB)  je 
fosfoinositid d   1 (PDK1), PDK2 a  
(shrnuto v publikaci Hennessy et al., 2005). 
  Bad 
(Datta et al., 1997) a - - ), 
o je metabolismus, proliferace a diferenciace. GSK-
  (Pap a Cooper, 1998; Olianas et al., 2011)
  




(Beurel a Jope, 2006). PI3 tu 






ERK1/2, extracellular signal-regulated kinases), c-Jun 
N- -3) a p38 ( ) (Raman et al., 2007) viz obr. 6. 
 OR mohou aktivovat mechanismy
nebo na G-proteinech (Law, 2011). echanismy na 
G- OR a jim bude 
.5. Desenzitizace a internalizace.  
 Na -proteinech se 
 podjednotka (Belcheva et al., 1998), PKC (Belcheva et al., 2005; 
Rozenfeld a Devi, 2007), PI3K (Kam et al., 2004), PI3K/Akt (Shahabi et al., 2006) a PKA 





Obr. 4: ma  Go/Gi  po aktivaci OR.  
 
2.3.5. Desenzitizace a internalizace  
em. 
(Luttrell 
a  Lefkowitz, 2002). Fosforylace   
-
   
(Lefkowitz, 1998), 
(Luttrell a Lefkowitz, 2002). 
Hla  ale  
desenzitizace - , 
G protein-coupled receptor kinases -arrestin.  na G  podjednotku 
a  ICS3 a cytoplaz  
receptoru. S , ale 
-arrestinu -proteinu. -arrestin 
hrinu a 
 . 
Po  nebo naveden 
do (Lefkowitz, 1998; Luttrell a Lefkowitz, 2002; Gurevich 
a Gurevich, 2006) viz obr. 5.  
Proces internalizace receptoru 
 ligandu  etropin i  rychlou internalizaci DOR 
a  KOR,  internalizaci ani jednoho z OR 
(Keith et al., 1996). Jedna ze st n jako   
OR indukuje jen takovou  m agonistou, 
fosforylaci cytoplaz   
(Schulz et al., 
2004). 
-arrestinem. 
 - -arrestin-knockout), ale vykazuje 
(Bohn et al., 1999)
morfinu -arrestin-
tolerance -
-arrestinu (Bohn et al., 2000). 
,  morfinem 
 
 sice GRK2/3 indukuje  
receptoru,   -arrestinu. 
 komplex MOR- -arrestin   




2. Internalizace:  
-arrestinem. 3. Recyklace/downregulace: V 
GPCR-  protein serin/threonin  
 ne (upraveno podle Luttrell 
a  Lefkowitz, 2002). 
 
 Cyklus desenzitizace  internalizace  recyklace x degradace je r
a     
recyklaci, absence 
internalizace po aktivaci morfinem zpomaluje  receptoru  
  
- Absence internalizace a 
desenzitizace receptoru na rozvoji 
(Martini a Whistler, 2007). 
 -arrestin hraje   v 
MAPK 
-arrestin tak  -
(Pierce a Lefkowitz, 2001; Reiter a Lefkowitz, 2006) viz obr. 6. 
 
Obr. 6: Aktivace -arrestinu. Vlevo: Po aktivaci 
aci:  MAPK 
MAPK  ERK, JNK a p38 spolu s K (MEK1, MKK4/7 a MKK 
3/6) a MAPKKK (RAF1 a ASK1). Vpravo: -arrestin jako 
MAPK (upraveno podle 
Pierce a Lefkowitz, 2001). 
 
 MAPK ,   - , jsou zpravidla 
-arrestinem 
 MAPK k vat 
(DeFea et al., 2000).  
  receptor- -arrestin je aktivace 
  (Luttrell et al., 1999) a fosforylaci 
dynaminu   end  receptoru (Miller et al., 2000).  
  
2.4. Toll-like receptory (TLR)  






E lad heat shock 
proteiny (HSP ) a fibronektin. Stimulace TLR indukuje aktivaci 
MAPK drah a u NF-  
. V -   
k y i  (Akira 
a Takeda, 2004).  
  ukazuje TLR4 a indukuje tak 
Morfin se 
d -  indukuje oligomerizaci TLR4/MD-  
aktivaci TLR4. 
TLR4/MD-  (Wang et al., 2012). Aktivaci 
TLR v CNS je  
(Hutchinson et al., 2007).  in vivo experimenty v morfinem 
 hyperalgezii an dily (Fukagawa et al., 
2013; Mattioli et al., 2014).  
 M3G, 
LPS ale morfin 
i  M3G  jen slabou aktivitu TLR4.  tak 
 (v , 
aktivitu TLR4 vyvolanou LPS (Xie et al., 2017). 
aktivaci MO
(Franchi et al., 2012). 
  TLR2 a 
- 
sepse, I-R . e 
 regulovat cytot
a 
naopak  k  
a (Mann, 2011). 
  endoto  -
srdce (Brown et al., 1989; Meng et al., 1997)  
po infarktu myokardu (Timmers 
et al., 2008) a inhibice   I-  srdce (Shimamoto et al., 
2006). ,  
v kardioprotekci i  
 Doposud ne   vlivem morfinu na 
by mohlo skrze 
aktivaci MOR  





2.5. Ischemicko- myokardu 
  jsou v 
17,7 m
  a 
s . Jejich rozvoji lze 
 
Z  
 i   - ICHS (World Health Organization, 2017) viz 
obr. 7. V  ICHS (infarkt myokardu 
a  57 
23 
informa ), 2016).  
 
 
Obr. 7: v 
(na 100 000 obyvatel,  pro rok 2008 (upraveno podle Mendis et al., 2011). 
 





 reperfuze (Ferdinandy et al., 2007). N
k  mu 
s poruchou stunning  -  myokardu), arytmiemi 
a  m  (Piper et al.,  1998).  
 e v 
respiraci,  
ktivuje Na+/H+ , H+ ven 
z  Na+ do Na+ v cytosolu indukuje aktivaci Na+/Ca2+ 
Ca2+. V ATP) 
Na+/K+- Na+ v  cytosolu, 
Ca2+. 
Ca2+ a Na+ 
  voda.  
k SR. Ca2+ y y, 
kter  Pokud nedojde k , SR 
  (Ferdinandy, et al., 2007; 
Hausenloy a Yellon, 2013), viz obr. 8.  
 u
+/H+ 
ku reenergizuje mitochondrie 
a  reaktivuje elektron-tr , 
, reactive oxygen species). 
Na 
 (Ferdinandy, et al., 2007; Hausenloy a Yellon, 2013).  
 Ca2+. 
u OS, 
 Ca2+. Regulace hladiny 
Ca2+  Ca2+ se kumuluje v cytosolu a v  








 Aktivita ROS 
chemoatraktant pro   
v   
 my 
a  ( ) . 
(Ferdinandy et al., 2007; Yellon a Hausenloy, 2007; Heusch et al., 2010; Hausenloy 
a  Yellon, 2013) viz obr. 8. 
 
 
Obr. 8: Sche  vedou  k ischemicko-reperfu
myokardu (upraveno podle Hausenloy a Yellon, 2013). 
2.6.  
 
2.6.1.   




k signifi -  
 S ohledem   
 v  (Boluyt et al., 1993) a po infarktu myokardu (Paradis et al., 
1992)  na 
 Tato teorie byla   
OR naloxon,   , 
IPC.  in vivo 
 (Schultz et al., 1995). 
v  in vivo (Chien 
a Winkle, 1996),   (Kunecki et al., 2017)  
u  (Tomai et al., 1999). 
Na  morfinu se i.v. 
hemat  (Schultz et al., 1997). 
Naopak z  CNS  (Lu et al., 2011). 
 
2.6.2.  conditioning 
 Vliv morfinu na I-R   na potkanech  
D bylo  vhodnosti   
myokardu.   
se  (Markiewicz et al., 1982). 
 in situ  0,3 mg/kg  dlouhodobou 
  
IPC (Schultz et al., 1996).   









procento z (upraveno podle Yellon 
a  Hausenloy, 2007).  
 
 MPC navozuje protekci v 
 
i   (Liang a Gross, 1999; McPherson a Yao, 2001)
v      pouze 
 -  (Liang a Gross, 1999). Naopak v in situ byly 
protektiv  - 3 mg/kg (Miki et al., 1998).  
 funkce 
 a tento i 
 remodelace , ke  
po infarktu v  a . 
Remodelace   (Liu et al., 2011).    
 Kardiop (Schultz et al.,  
1997; Okubo et al., 2004). 
 DOR1 (Liang a Gross, 1999; McPherson a Yao, 2001). 
in 
OR (Lu et al., 2011). Recen  ukazuje  m 
do  v  
 exprese MOR. Aplikace morfinu pak sni uje v -R 
  skrze aktivaci MOR (He et al., 2018). 
 nejsou  
v   mechanismy. 
 
2.6.2.1. ch ch K+  a produkce ROS 
  protekci  
K+ (mitoKATP  produkci . Blokace 
mitoKATP i blokace produkce nhibovala 
v  (McPherson a Yao, 2001) 
(Peart a Gross, 2003). Aktivace mitoKATP   
 v morfinem H9c2 kardiomyoblas
hladina ROS inhibovala protein serin/threonin  (PP2A)   
aktivity azovalo 
protekce jako  morfinu (Xu et al., 2011). 
 et al. (2010)  MPC byl 
v na aktivaci Ca2+ ch K+ (mitoKCa) 
. mitoKCa  Dorsch et al. (2016) 
otestoval pro  efekt  
- H-  
MPC ,  
opioi  AC a 
 (Williams et al., 2001)  ale 
pr  zde i dva inhibitory PKA  H-89 a PKI (14-22 
amid) H-
 -89 pro PKA (Peart a Gross, 
2006).  
    morfinu 
  na aktivaci sarko  K+ (sarcKATP
(Schultz et al., 1996; Liang a Gross, 1999). V  ale ke studiu vlivu 
sarcKATP glibenclamide,   
mitoKATP  Kardioprotekce - TAN-67 nebyla ale 
m inhibitorem sarcKATP  - HMR 1089. Aplikace HMR 1089 
la ila 
kt  postihly  (Fryer et al., 2000)  aktivace 
sarcKATP  v  
 
2.6.2.2. Aktivace PKC 
 Aktivace PKC    (Miki 
et al., 1998)  (Peart a Gross, 2006). K 
 IP3 2+
aktivuje PKC (Barry a Zuo, 2005). K 
byl 2+ 
-Lemaire et al., 2005).  s oval 
kardiomyocytech sk PKC-  
(Zhang et al., 2002)
 .   
 
2.6.2.3.   Inhibice GSK-  a  mPTP 
 GSK-3  
(Gross et al., 2004). Inhibice GSK- zamezuje  a tak 
  s
 extenz   (Juhaszova et al., 2004; Obame et al., 2008). 
Inhibitor GSK-3  (SB 216763)   -
MPC. Pro inaktivaci GSK-3  Ser9
MPC u potkana tuto fosforylaci   mTOR (mammalian target of 
rapamycin), PI3K (Gross et al., 2004) a ERK (He et al., 2015). PI3K/Akt a 
ERK    ( u 
nebo bradykininu jsou 
reperfusion injury salvage kinase) (Hausenloy a Yellon, 2004).  




translocase of the outer 
membrane) a  (Small et al., 2015). 
identifikovala 
proteiny, k N  
 do mitochondrie ,  
(Barksdale a Bijur, 2009) nebo PKC-  (Budas et al., 2010). P  je 
aktivita Akt v 
se  regulace respirace, K+  (Lim et al., 
2016).   translokace  
 
 Na modelu y  
 NO/cGMP/p G (PKG)   
i Zn2+. 2+ inhibuje GSK-
(Xi et al., 2010). Zn2+ v 
(Zhang Y. et al., 2013)
inhibuje aktivitu komplexu I 
elektron- (He, H. et al., 
2016).  
 
 2.6.2.4.  
 Janus tyrozin  (JAK)
transkripce (STAT, signal transducer and activator 
reagovat   a v 
regulovat genovou transkripci (Bolli et al., 2003). JAK/STAT si zpravidla 
 receptory, kte   cytoplaz   
obsahuje  pro JAK. Dimerizace receptoru 
molekul JAK  
  STAT. 
 
a aktivuje nebo  . 
, r. Aktivaci mohou ale 
  (RTK) a (Rawlings et al.,  2004).  
 Gross et al., (2006) popisuje  bylo 
u o -
ilo 
byla    PI3K. Z  
 stalku s
a  JAK/STAT.  studie Dorsch et al., (2016) 
STAT3  .   
 je p    
studie   
spojeno s studie 
 je  
(EGFRTK, epidermal growth factor receptor tyrosine kinase). EGFRTK 
 produkce ROS a  Akt (Xu et al., 2012).  
 
2.6.2.5. Crosstalk s  
 Morfin i agonista A1  (AR  
navodit protekci proti I-  . Pokud ale dojde k 
kardio  aktivace A1AR aopak, blokace A1AR inhibuje 
aktivace  ce A1AR i OR 
 A3AR a to i v -  
(Peart a Gross, 2003).  
 
 crosstalk s RTK (Xu et al., 2012).   
  zapojena aktivace 2-AR a s (Peart 
a Gross, 2006).  
 
2.6.2.6. MikroRNA 
 MikroRNA (miRNA) jsou ,  
translace jejich essenger RNA. studie  
miRNA do ho efektu MPC. 
kardiomyocytech indukuje MPC 
K miR-133b-5b,   expresi proteinu Fas. 
 
  H9c2 
overexprese miR-133b- , inhibice 
miR-133b-5b  (He, S.-F. et al., 2016).  studie tyto 
 
-regulovat miR-133b-5b, down-regulovat expresi 
protein -  
,   (Zhu 
et al., 2017). 
 
2.6.2.7.  postconditioning 
P u   
vykazuje kardioprotekce jako MPC (Gross et al., 2004). 
ale  protekce, 
je 
(Chen et al.,  2008).  
 Kardiop MPOC (Jang 
et al., 2008; Kim et al., 2011), (Kim et al., 2011)
u na KOR 
a  protekci roli. Z  
oru OR naloxonu, inhibitoru 
DOR a inhibitoru KOR (Chen et al., 2008). 
 MPOC je v 
s  
  2+ a  
rezistenci k o     , 
ale 
mPTP.  idaci,  
 produkci ROS.  
-3   SB 216763 (Obame et al., 2008) a je tak 
 inhibice 
GSK-3  (Gross et al., 2004).  MPOC 
zpr PKG (Jang et al., 2008). 
 je MPC a vede k 
i Zn2+ 2+ -
(Xi et al., 2010). 
 
 sarcKATP  (Gross et al., 2007), mitoKATP (Gross et al., 2007; Chen et al., 2008) 
a  mitoKCa (Huhn et al., 2010). Aktivace sarcKATP a mitoKATP 
 PI3K. KATP a mitoKATP 
 216763 (Gross et al., 2007). 
 , MPOC    v 
trabekule (Fuardo et al., 2013)  potk . V 
   I- inhibovat 
a  c (Chen et al., 2016a; Chen et al., 2016b). Tento 
k  efekt je  MAPK (Chen et al., 2016b) 
a  - , indukuje fosforylaci (a aktivaci) ERK, 
 (Chen, et al., 2016a). MPOC zvy  
(Mourouzis et al., 2009)
a stabilizuje aktin (Peart et al., 2007). 
 
 velmi podo   
Chen et al. (2016b
Zhang et al. (2007  
  nastat 
(Headrick et al., 2015). 
Obr. 10: P drah 
s morfinu  -
mPTP a degradaci HSP90. Src kin
elektron-transportn  extenzi
MicroRNA (miR-133b-  indukci 
(   motifolio.com). 
 
2.6.2.8.  
chorob (Mann, 2011) kapitole 2.5. Ischemicko-
  po reperfuzi, 
 (Hausenloy a Yellon, 
2013). 
 3 s infarktem myokardu do  
k   ICAM-1 (int
L- js  
z    aktivitu 
(Wang et al., 1997)
 NEP -1 
a gp100MEL14 ( -selektinu) a at  MPC 
(Wang et al., 1998).  
endotelinu (ET), 
hemo   hladina ET je 
 (Omland et al., 1994).  
 
u  (Wang a Chang, 2001) a 
(Wang a Hung, 2003) . 
 
2.6.3.  
  roce 1987  3   
zalo 
 myokardu 
(Chan et al., 1987). 
modelu, 
75  experiment  
chronic MPC zal navodit  
I-  (Peart a Gross, 2004a, 2004b, 2006; 
Peart et al., 2011). byl ChMPC  
(Peart et al., 2011) od MPC zal navodit kardioprotekci 
 (Peart a Gross, 2004a).  
 hMPC DOR, s 2-AR a 
i PI3K. Na  ale i, PKC, mTOR, cRaf1 
ERK , mitoKATP . Rol
 
zcela ro (Peart a Gross, 2006; Peart et al., 2011). e 
MPC a MPC 
zes
  MPC 
s  (Peart et al., 2011). P  ChMPC je   
spojen s exprese  
exprese ko .  
k regulaci komponent   
Naopak exprese   
 (Ashton et al., 2013).    
  preconditioning 
- 2 h ,  - 3 dny. 
  
 
  (Williams-Pritchard et al., 2011). Dlouho
 ale . 
P  preconditioningu by tak bylo 
u   
y (Peart a Gross, 2004a).  
 
2.6.4. M  conditioning  
   se stal conditioning 
(RIPC, remote ischemic preconditioning).    
,  . 
ischemie a repe   
. RIPC  v 




 D  EOP a aktivace 
(Wong et al., 2012a). Aplikace morfinu pak 
pro  RIPC. jeden cyklus ischemie/reperfuze 
RIPC nebo morfinu nejsou , 
cykly ischemie/reperfuze RIPC (Lu et al., 2012). 
 Zahn et al.  (1997 pro  modulace bolesti 
i.v. 1000x me i.t.; 
 
). Groban et al. (2004
orfinu po   preconditioningu na 
   y morfinu (0,3  i.t.  
velikost infarkt  
 
  RMPC  MOR, KOR i DOR 
(Li et al., 2009) v CNS  zapojeny nejsou (Wong et al., 
2010). P   
(Wong et al., 2012b)  
(Headrick et al., 2015) jako je adenosin (Yao et al., 2011), bradykinin (Wong 
et al., 2012b) a  (CGRP, calcitonin gene-related 
peptide) (Zhang et al., 2011; Wong et al., 2012b)
svou schopnost indukovat kardioprotekci (Kleinbongard et al., 
2017).  
 N pak  
mechanismech  RMPC. 
1)  NOS/NO/GC/cGMP/PKG  
v CNS (Lu et al., 2015)   (Yao et al., 2011).  
 
2) V CNS   OR ke  kalmodulinu 
(   hladiny  
(Zhang et al., 2011).  CaM 
 aktivovat NOS (Spratt et al., 2007) 
CGRP (Du et al., 2004).  
CaM/NOS/NO/CGRP. 
 
3) V  se zvy   (eNOS) a KATP . 
CGRP a bradykininem (Wong et al., 2012b). V 
bradikinin indukoval kardioprotekci 
PI3K/Akt/eNOS (Bell a Yellon, 2003). 
 
     
(RMPOC).     MOR, KOR a DOR 
v CNS, 
aktivace AR  (Ling Ling et al., 2010) 
 NOS/NO/GC/cGMP v CNS (Jiang et al., 2016).  
 
2.6.5. I  
 Murphy et al. provedl vzorku 46 (2006), 30 (2007) 
bypassu (CPB)
- 
(Murphy et al., 2006)





hladinu troponinu , l 
jednotce intenz JIP) (Omran, 2017)
 i.t. e  RMPC. Skupina 22 
a  JIP (Elgendy a Helmy, 2017).  




k rozvoji ventriku k rozvoji ICHS, i.v. 
morfinovou  
 xistovaly obavy,  




druhem anestezie (Asaf et al., 2011). Podobn ale , 
. CPB
v 0,1 mg/kg 
 hladinu 
troponinu,    pobytu na JIP (Zhang R. 
et al., 2013). 
  
infarktem myokardu  elevacemi ST 
 (STEMI, ST elevation myocardial infarction). K aplikaci morfinu  
zpravidla u  n  
. 
 se STEMI ale ne
zcela . Podle  de Waha et al. (2015) byla i.v. aplikace 
morfinu u p  se STEMI (n = 123)  kontrolami (n = 153) spojena s 




. Tento fakt Farag et al. (2018), 
m se STEMI sice spojeno 
u
Ib/IIIa,  , 
uze.   
  
infarktu. Aplikace 5 mg morfinu 30 min 
-d 
-
reperfuze (Eshraghi et al., 2017). T
 i.v. aplikace 5 mg morfinu 
a RIPC navozuje,  u
Rentoukas et al., 2010).  
  
STEMI. Gwag et al. (2017) 
reperfuzi 3 mg mo
s  
reperfuze. V Bonin et al. (2018) pak provedla 
cel , z 
 v
infarktu,  ani  






















3.1.1. Model in vivo, potkan kmene Wistar 
1)   morfinu na expresi a aktivitu 
 







iTRAQ ( isobaric tag for 
relative and absolute quantitation) po  3 nebo 
 
6)  expresi 
 
 
3.1.2. Model in   
7) 
t-BHP. 
8) Zkoumat vliv morfinu na  
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5. Seznam metod 
 
5.1.  
 K  ) byli  
 byl i.m.  v 
stejnou dobu i.m.   
P  a 3), 
 usmrceny 3  . Abychom 
 je  
2) byly zahrnuty   
s morfinem  i.m. naloxon v  10 mg/kg/den 
byl po ste  
. 
 
obohacenou o plaz   
 
5.1.2.  
 V  fr   
a  
AC V/VI, HSP27, p-HSP27 (Serin 82), p-HSP27 (Serin 15), HSC70 (
heat shock proteinu 70, heat shock cognate 71 kDa protein), ORP
gen regulated protein) a GRP  
 
5.1.3.  
  a afinita - 1- 2-AR) 





- Stanovena byla A) b  AC, 
B) s  AC   (MnCl2, 
10 s 
a  skrze akti -  C) aktivita AC 
    DOR [D-Ala2, D-Leu5]-
enkefalin (DADLE, 10    
 
5.2.  
  )  
. - 80% konfluenci 
 
 
- FBS)    1% 
FBS)  
morfin, nebo pouze s PBS ( skupina). 
  t-BHP na 15 h.  
 
a  morfinem (1   t-BHP v rozsahu 100  . 
  a 








5.2.1.1. MTT test 
  3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide - MTT (Mosmann, 1983)  metabolicky 
 
. Tyto krystaly lze rozpustit dimethylsulfoxidem 
a   spektrofotometricky.   
 
5.2.1.2. LDH test 
 Cytotoxicita b   
v mediu
  




 P  zastou   stanoveno 
   Annexin V/Hoechst 33258. Annexin V detekuje 
Hoechst 33258 , 
  . K 
 
 ilo (Annexin V/Hoechst 
33258 Annexin V /Hoechst 33258 
Annexin V/Hoechst 33258  nekrotickou (Annexin V 






 esej  na sc
 -azino-di-[3- - ABTS, ke 
 
 
5.2.2.2.  Sta  ROS  
  ROS bylo stanoveno 
-dichlorodihydrofluorescin 2DCF- 2DCF-DA vstupuje 
   
-dichlorohydrofluorescin (DCFH). V 
lorofluorescinu (DCF). V 
 cytometrie. 
 
5.2.2.3.   
 - karb , byla stanovena 
-dinitrofenylhydrazinu (DNPH). DNPH reaguje 
 
spektrofotometricky (Levine et al., 1990). 
 
5.2.2.4.  
 byla  kolorimetrickou metodou TBARS (thiobarbituric 
acid-reactive substances




roteiny: Bcl-2, Bax, 
 MAPK, p-  MAPK (Threonin 180/Tyrozin 182), GSK- -GSK- (Serin 9), 
 
    
5.3.  
 
  -testu 
nebo -Newman-Keuls 
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G-  .  
 
- z -
(Gs i/o z q/11 ).   ale sobilo 
 2, forskolinem, NaF  
 
DOR (DADLE) a KOR (U50488) inhibovat forskolinem stimulovanou aktivitu AC byla 
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  mitochondrie. Z 
  
v  
-B crystallin, HSP10, HSP60 
a   MAPK (izoformy 
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 t-BHP (15 h) ace 
s morfinem (15 min) 




anti- -2/pro- -p38/p38 MAPK 
a p-GSK- -  t-BHP 
a -2/Bax, p-p38/p38 MAPK a p-GSK- -   
 expresi  vliv na expresi SOD1. 
SB  
viability o  
  
  t-BHP. Toto 
 hami p38 MAPK 














- s i/o z q/11
morfinu ale 
MnCl2  100 %. Naopak 
 
 - -
s,  1-AR 
a  2- 1- -AR 
(Rockman et al., 2002)
-AR noradrenalinem i enkefaliny (Wilson et al., 
1980)
signalizace. V -AR 
2+ 
spojenou kontraktilitu srdce (Pepe et al., 1997; Xiao et al., 1997) -AR tak 
 -
2- s 
(Peart a Gross, 2006)
a  
To Kindman et al., (1991)
-
-AR 
v (Hejnova, et al., 2017) 
(Ammer a Schulz, 1997)





aktivaci i/o a G   inhibici AC I, V, VI a VIII a stimulaci AC II, 
a superinhibici AC II, IV a VII (Schallmach et al., 2006)
s (Sharma et al., 1975)
-arrestin-
 rozvoji tolera (Bohn et al., 
2000)
(Avidor-Reiss et al., 1996; Ammer 
a Schulz, 1997; Schallmach et al., 2006) (Duman et al., 
1988; Bohn et al., 2000; Hejnova et al., 2017)
5,75 (Napier et al., 1999). 
Napier et al., (1999) ve   nebo 
Bohn et al. (2000
u et al. 
 AC v locus coeruleus, ale nikoli 
ve striatu. 
 Z  
- s  
em stimulovanou aktivitu AC je 
forskolinem stimulovanou enzymovou aktivitu 
 
- a VI jsou 
(Iyengar, 1993; Espinasse et al., 1995)  za 
 
s 
 2-AR (Ammer a Schulz, 1997; 
Hejnova et al., 2017) a i/o a G (Avidor-Reiss et al., 1996), MAPKKK Raf-1 
 (Yue et al., 2006) a PKC (Schallmach et al., 2006)
superaktivaci 
(Steiner et al., 2005) a nelze  downregulaci 
(Mayr 
a Montminy, 2001)
2- - s i/o z q/11





v  Chan et al., 1987) 
(Peart a Gross, 2004a, 2004b, 2006; Peart et al., 2011). 
- inu. 
 jejich 
(Marmor et al., 2004)












v cytosolick ALDH2, PITP, HSP27) 
a  
 
a PI3K (Cockcroft a Garner, 2011)
p38 MAPK k indukci exprese 
Ikeda et al., 2008)
T a MVP upregulovat 





(Wang et al., 2002)
 aktin 
 (Matsson et al., 2008). Degradace 
desminu -





chorob (Chen et al., 2010) -R 





(Yu et al., 1999; Cechowska-Pasko et al., 2006). Velkou podskupinou 
 








3  8  
a  (De Gregori et al., 2012), M3G 
et al., 1996)
(Xie et al., 2017)
 
chorob (Mann, 2011). Stimulace TLR n (Akira 
a Takeda, 2004). Doposud  ne   vlivem 
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